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Effect of pregnancy on growth of intracranial meningiomas
Ayesha Quddusi, Muhammad Shahzad Shamim Quratulain Virani

Abstract
Meningiomas are the most common benign primary
intracranial tumours in adults. Their rapid growth during
pregnancy has been well reported. Moreover, the
relationship of increased progesterone expression during
pregnancy and extensive tumour growth has been
debated. In this review, we discuss not only the effect of
progesterone on meningiomal growth but also other
mechanisms involved in gestational meningiomas.
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Introduction
Meningiomas are the most common primary intracranial
tumours, representing one-third of all intracranial tumours
in adults.1 A higher incidence is observed in women as
compared to men.2 According to a recent review article,
the incidence of meningiomas in pregnancy is 5.6 in
100,000 pregnant women.3 This low incidence is noted
because the range of fertility is approximately 15-45 years
of age whereas meningiomas more frequently present in
in 6-7th decade of life.Although meningiomas are usually
slow-growing, they can exhibit aggressive characteristics
during pregnancy.4 A possible explanation for aggressive
growth during gestation can be the changes in female
sex hormones.In this review, the authors summarize the
evidence exploring the association between pregnancy
and meningioma growth.
Review of evidence
We reviewed articles on Pubmed describing the effect of
pregnancy on meningioma growth and the pathogenesis
by which this occurs. The earliest literature on tumours in
pregnancy was published by Barnard in 1898.5 One of the
initial papers discussing meningiomas in pregnancy was
a case report, published in 1929 by Cushing and
Eisenhardt, on a pregnant woman with parasellar
meningioma. They reported rapid progression of visual
impairment which was reversible post-partum and
recurred in the next pregnancy.6 Smith et al., in 2005
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Figure 1a,b: MRI Brain T1WI with gadolinium enhancement, showing a
homogenously enhancing mass in right frontal region, histologically
proven to be a meningioma. Corresponding post-operative section
shows complete tumour resection.
published a sex steroid and growth factor profile of a
meningioma associated with pregnancy, and showed
significant expression of progesterone receptor (PR),
platelet-derived growth factor receptor B (PDGFRB),
fibroblastic growth factor receptor 2 (FGFR-2), whereas,
no significant expression of estrogen receptor (ER),
epidermal growth factor receptor (EGFR) and human
placental lactogen (hPL) was seen.7 Hatibogluet al., in
2008 described three patients with meningioma who
presented in their post-partum period.
Immunohistochemistry of their resected tumours showed
increased expression of not only PR, but also EGFR
expression.8 Kerschbaumeret al., in a recent case report
showed regression of a gestational meningioma in the
post-partum period, that also supports the idea of the
hormone-sensitive nature of these tumours. Interestingly,
histopathology of the resected tumour also showed more
than 90% PR expression, thereby showing the effect of
increasing levels of progesterone in pregnancy on the
rapid growth of meningiomas.9
In contrast to this, an article in 2012 studied 17 clinicopathological cases of meningiomas in pregnancy. They
reported that all but two tumours had extensive PR
expression whereas only one had minimal estrogen
expression. However, PR expression was also similar in
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the specimen from the control group. Hence, it was
unlikely that progesterone alone explained meningioma
growth during pregnancy. Their case series also provided
evidence against cellular proliferation as a factor in
accelerated tumour growth. Furthermore, they found five
cases in which there was tumoural hypervascularity,
edema, and haemorrhage/necrosis, which suggested that
haemodynamic changes could also potentially explain
the rapid tumour growth during pregnancy and its postpartum regression.10
An article in 2017 also reviewed these two cardinal
mechanisms behind the pathogenesis of meningioma
growth in pregnancies, which are: endocrine and vascular.
According to them, high level of progesterone and the
presence of increased vascularity and intra- or extracellular
oedema are responsible for the aggressive nature of
gestational meningiomas. However, progesterone
receptor is expressed not only in meningiomas of females
but also in those of males and children. Moreover, the
peak incidence of meningiomas is far beyond the fertile
age when the serum level of progesterone is relatively
low. Furthermore, the reversible nature of haemodynamic
changes i.e. the regression of the tumour after childbirth,
suggests that it plays a role in tumour growth. However,
these changes are not always present in gestational
meningiomas. Hence, they concluded that endocrine and
vascular mechanisms do not act independently. Rather,
both are responsible for the unusual behaviour of
gestational meningiomas.4
Lavivet al., published a comprehensive review of clinical
cases of intracranial meningiomas and looked at the
potential factors involved in the pathogenesis of
meningioma growth during pregnancy. They theorized
that the pathogenesis involved a pituitary-related
hormone, and that is responsible for the rapid growth of
meningiomas in pregnancy.11 This was based on the
observation that most cases had meningiomas in the
parasellar location and there was a significant association
with the internal carotid artery for vascular supply.11 They
proposed prolactin as the hormone that acts as the key
contributor for the rapid growth (and shrinkage) of
meningiomas during pregnancy because it not only fits
the a bove descr iption bu t it als o composes

osmoregulation capabilities that influence the tumour
size in a reversible manner.11

Conclusion
We conclude that pregnancy impacts meningioma growth.
Possible pathogenesis has been associated with changes
in the level of progesterone during gestation. However,
evidence also exists to the contrary hence the role of
progesterone in gestational meningioma growth remains
debatable. The role of progesterone and estrogen
receptors in meningiomas has been previously studied
extensively. More recent articles have theorized changes
in vascularity during gestation, and prolactin levels as
possible mechanisms of aggressive meningioma growth.
These mechanisms, particularly the role of prolactin should
be further investigated to obtain more conclusive
evidence.

References
1.

Quddusi A, Shamim MS. Simpson grading as predictor of
meningioma recurrence. J Pak Med Assoc 2018;68:819-821.
2. Wiemels J, Wrensch M, Claus E.B. Epidemiology and etiology of
meningioma. J Neurooncol 2010; 99: 307-314.
3. Dumitrescu BC, Tataranu LG, and Gorgan MR. Pregnant woman
with an intracranial meningioma: case report and review of the
literature. Rom J Neurosurg 2014; 21: 489-496
4. Hortobágyi T, Bencze J, Murnyák B, Kouhsari MC, Bognár L, MarkoVarga G. Pathophysiology of meningioma growth in pregnancy.
Open Med (Wars). 2017;12:195-200.
5. Bernard MH. Sarcome cerebral à evolution rapide au cours de la
grossesse et pendant les suites des couches. Bull la Socd'Obstetrique
Paris. 1898; 1:296-298. (In French)
6. Cushing H, Eisenhardt L. Meningiomas arising from the tuberculum
sellae. Arch Ophth. 1929;1:168-205.
7. Smith JS, Quinones-Hinojosa A, Harmon-Smith M, Bollen AW,
McDermott MW. Sex steroid and growth factor profile of a
meningioma associated with pregnancy. Can J Neurol Sci.
2005;32:122-7.
8. Hatiboglu MA, Cosar M, Iplikcioglu AC, Ozcan D. Sex steroid and
epidermal growth factor profile of giant meningiomas associated
with pregnancy. Surg Neurol. 2008;69:356-62.
9. Kerschbaumer J, Freyschlag CF, Stockhammer G, Taucher S, Maier
H, Thome C, et al. Hormone-dependent shrinkage of a sphenoid
wing meningioma after pregnancy: case report. J. Neurosurg.
2016;124:137-40.
10. Lusis EA, Scheithauer BW, Yachnis AT, Fischer BR, Chicoine MR,
Paulus W, et al. Meningiomas in pregnancy: a clinicopathologic
study of 17 cases. Neurosurgery. 2012;71:951-61.
11. Laviv Y, Ohla V, Kasper EM. Unique features of pregnancy-related
meningiomas: lessons learned from 148 reported cases and
theoretical implications of a prolactin modulated pathogenesis.
Neurosurg Rev. 2018;41:95-108.

J Pak Med Assoc

